Medinova Diagnostic Services Share Price

CMP as on22-Oct-20 15:29

₹ 13.85
0.45 3.36%

Open

₹ 13.01

Turnover (lac)

Prev. Close

₹ 13.40

Day's Vol (shares)

₹ 9,861

Day's Range

₹ 13.00
₹ 14.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 04-Aug-2020 - -
MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2020 ,inter alia, to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the first quarter ended 30th June, 2020.
Board Meeting - 15-Jun-2020 - -
MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/06/2020 ,inter alia, to consider and approve the Audited Financial Results (Standalone & Consolidated) for the 4th Quarter and Financial year ended March 31, 2020. In compliance with Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith statement containing the Audited Financial Results (both standalone and consolidated) for the 4th quarter and financial year ended 31st March, 2020 which have been reviewed by the Audit Committee and approved by the Board at their meetings held on 23rd June, 2020 along with Audit Report and declaration pursuant to Regulation 33 (3) (d) (for unmodified opinion). (As Per BSE Announcement dated on 23.06.2020)
Board Meeting - 25-Jan-2020 - -
MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2020 ,inter alia, to consider and approve the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the Third Quarter ended 31st December, 2019. Newspaper Publication-Notice of Board Meeting scheduled to be held on 04.02.2020 (As Per BSE Announcement dated on 28/01/2020) In compliance with Regulation 33 & 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the enclosed Un-Audited Financial Results for the Third Quarter ended 31st December, 2019 (Standalone and Consolidated) which have been reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on February 4, 2020 and also the Limited Review Report furnished by the Statutory Auditors of the Company. In compliance with Regulation 33 & 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the enclosed Un-Audited Financial Results for the Third Quarter ended 31st December, 2019 (Standalone and Consolidated) which have been reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on February 4, 2020 and also the Limited Review Report furnished by the Statutory Auditors of the Company. (As Per BSE Announcement Dated 04.02.2020)
Board Meeting - 29-Oct-2019 - -
MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2019 ,inter alia, to consider and approve the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the Second Quarter and Half Year ended 30th September, 2019. ntimation of Appointment of Chief Financial Officer Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015, We would like to inform that the Company has appointed Mr. Hrusikesh Behera as Chief Financial Officer and Whole Time Key Managerial Personnel of the Company in terms of Section 203(iii) of Companies Act, 2013 w.e.f. 07th November, 2019 at its Board meeting held on Thursday, 07th November, 2019. (As Per BSE Announcement Dated on 08/11/2019)